FI50416C - Menetelmä uusien terapeuttisesti käytettävien trisubstituoitujen oksat solien ja tiatsolien ja näiden happoadditiosuolojen valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käytettävien trisubstituoitujen oksat solien ja tiatsolien ja näiden happoadditiosuolojen valmistamiseksi

Info

Publication number
FI50416C
FI50416C FI304067A FI304067A FI50416C FI 50416 C FI50416 C FI 50416C FI 304067 A FI304067 A FI 304067A FI 304067 A FI304067 A FI 304067A FI 50416 C FI50416 C FI 50416C
Authority
FI
Finland
Prior art keywords
thiazoles
sols
trisubstituted
branches
preparation
Prior art date
Application number
FI304067A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI50416B (xx
Inventor
Kevan Brown
John Frederick Cavalla
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of FI50416B publication Critical patent/FI50416B/fi
Publication of FI50416C publication Critical patent/FI50416C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI304067A 1966-11-18 1967-11-10 Menetelmä uusien terapeuttisesti käytettävien trisubstituoitujen oksat solien ja tiatsolien ja näiden happoadditiosuolojen valmistamiseksi FI50416C (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14

Publications (2)

Publication Number Publication Date
FI50416B FI50416B (xx) 1975-12-01
FI50416C true FI50416C (fi) 1976-03-10

Family

ID=27516268

Family Applications (1)

Application Number Title Priority Date Filing Date
FI304067A FI50416C (fi) 1966-11-18 1967-11-10 Menetelmä uusien terapeuttisesti käytettävien trisubstituoitujen oksat solien ja tiatsolien ja näiden happoadditiosuolojen valmistamiseksi

Country Status (12)

Country Link
JP (1) JPS4938267B1 (xx)
BE (1) BE706625A (xx)
CH (9) CH528531A (xx)
DE (2) DE1795822C2 (xx)
ES (1) ES347319A1 (xx)
FI (1) FI50416C (xx)
FR (2) FR1584222A (xx)
IL (1) IL28803A (xx)
LU (1) LU54891A1 (xx)
NL (1) NL157012B (xx)
PL (1) PL72562B1 (xx)
SE (2) SE369307B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (xx) * 1974-07-18 1976-01-30
JPS5182675A (xx) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
GB1543154A (en) * 1975-05-02 1979-03-28 Lilly Industries Ltd Urea and carbamate derivatives
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
CA2396738C (en) * 1990-11-30 2006-08-29 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
EP0772606A1 (en) * 1994-07-27 1997-05-14 G.D. SEARLE & CO. Substituted thiazoles for the treatment of inflammation
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (xx) * 1965-10-07

Also Published As

Publication number Publication date
BE706625A (xx) 1968-05-16
CH556351A (de) 1974-11-29
DE1670005C2 (de) 1982-06-09
PL72562B1 (en) 1974-08-30
LU54891A1 (xx) 1968-02-08
CH560203A5 (xx) 1975-03-27
FR8018M (xx) 1970-08-03
NL157012B (nl) 1978-06-15
DE1670005A1 (de) 1970-08-06
SE422209B (sv) 1982-02-22
CH528531A (de) 1972-09-30
DE1795822C2 (de) 1982-07-15
ES347319A1 (es) 1969-05-16
IL28803A (en) 1974-05-16
CH536311A (de) 1973-04-30
CH545310A (de) 1973-12-15
CH545308A (de) 1973-12-15
FI50416B (xx) 1975-12-01
CH560205A5 (xx) 1975-03-27
NL6715532A (xx) 1968-05-20
CH545309A (de) 1973-12-15
FR1584222A (xx) 1969-12-19
JPS4938267B1 (xx) 1974-10-16
CH554884A (de) 1974-10-15
SE369307B (xx) 1974-08-19

Similar Documents

Publication Publication Date Title
FI42712C (fi) Menetelmä terapeuttisesti vaikuttavien bifenyylialkaanijohdannaisten valmistamiseksi
FI50416C (fi) Menetelmä uusien terapeuttisesti käytettävien trisubstituoitujen oksat solien ja tiatsolien ja näiden happoadditiosuolojen valmistamiseksi
FI46154C (fi) Menetelmä terapeuttisesti käytettävien diaminobentsofenonien ja niiden happoadditiosuolojen valmistamiseksi.
FI49024C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen antraliinihap pojen emäksisesti substituoitujen amidien ja niiden suolojen valmistam iseksi.
CH476002A (de) Verfahren zur Herstellung von therapeutisch wirksamen Indolylmethyl-tetrazolen
FI47881C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyyliasetamidi en valmistamiseksi
FI41652C (fi) Menetelmä penisilliinien ja niiden myrkyttömien suolojen valmistamiseksi
FI45450C (fi) Menetelmä terapeuttisesti käyttökelpoisten fentiatsiini-johdannaisten ja niiden suolojen valmistamiseksi
PH9433A (en) Process for the preparation of 7-aminocephalosporins and acid addition salts thereof
FI50423C (fi) Menetelmä 6-aminopenisillaanihapon valmistamiseksi
FI44596C (fi) Menetelmä sulfonyyliuretaanien ja niiden suolojen valmistamiseksi
FI46955C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-alempi-al kyyli-5-alempi-alkoksi-3-indolyyli-etikkahapon valmistamiseksi
FI44229C (fi) Menetelmä analgeettisten beeta-tyydyttämättömien-beeta-hydroksi-beeta-fenyylietyyliamiinien ja niiden happoadditiosuolojen valmistamiseksi
FI47880C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyylietikkahap pojen valmistamiseksi
BR6676263D0 (pt) Processo para a preparacao de acido monofluor-fosforico e seus mono-esteres
NO138768C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-fenylacetamidocefalosporansyrederivater
BR6680070D0 (pt) Processo para a preparacao de esteres de acido-alfa-aminocarboxilico
FI32770A (fi) Menetelmä N-sykloalkyylisulfamiinihappojen ja niiden suolojen valmistamiseksi
FI41272C (fi) Menetelmä terapeuttisesti aktiivisten 4- tai 5-aryyli-1-naftyylietikkahappojen ja niiden johdannaisten valmistamiseksi
FI47879C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyylietikkahap pojen valmistamiseksi
FI42963C (fi) Menetelmä valmistaa uusia sekundääristen aminoalkoholien estereitä ja niiden happoadditiosuoloja
FI43997C (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliinijohdannaisten valmistamiseksi
FI48073C (fi) Menetelmä terapeuttisesti vaikuttavien sulfamoyyliantraniilihappojohda nnaisten valmistamiseksi
FI44408C (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliinijohdannaisten valmistamiseksi
FI42333C (fi) Menetelmä terapeuttisesti aktiivisten 11-piperatsinyyli-dibentsosykloheptadieeni-johdannaisten valmistamiseksi